Americas Hematology Diagnostics Market
Americas Hematology Diagnostics Market Analysis By Kit (Hematology Anemia and Iron Test Kits, Folic Acid Testing Kits, Sickle Cell Screening Kits, PT/INR Testing Kits, Blood Typing Kits), By Modality (Point of Care, Lab-based testing), By Distribution Channel, By Region - Global Insights to 2031
Analysis of Americas Hematology Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Americas Hematology Diagnostics
As per industry analysis of the Americas hematology diagnostics market, revenue totaled US$ 264 Mn in 2020, according to Fact MR. The market is expected to progress at a CAGR of 5% through 2031.
The U.S. is the most lucrative market in the region and is projected to account for over 77% market share by the end of 2031.
Key Insights Covered in Americas Hematology Diagnostics Industry Survey
- Market Estimates and Forecasts 2016-2031
- Key Drivers and Restraints Impacting Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Demand for Hematology Analyzer Machines
- Demand for Hematology Reagents
- Sales of Hematology Flow Cytometers
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Americas Hematology Diagnostics Market and How to Navigate
- Recommendation on Key Winning Strategies
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Hematology Diagnostics in the America from 2016-2020 Vs Market Outlook for 2021-2031
According to Fact MR, a market research and competitive intelligence provider, value of the Americas hematology diagnostics market was US$ 264 Mn in 2020. This industry entails testing of blood, blood forming organs, and blood diseases. Some of the common conditions diagnosed using hematology test kits include anemia, inflammatory diseases, blood cancer, and others.
There are various kits present for the purpose hematology diagnosis, such as anemia and iron test kits, folic acid testing kits, sickle cell screening kits, PT/INR testing kits, d-dimer testing kits, blood typing kits, leukemia testing kits, sepsis testing kits, antibiotic resistance panels, and bacterial & fungal panels. These kits are gaining popularity due to increasing demand for improved healthcare facilities.
Research is the focus for players dealing in hematology diagnostics. This results in frequent product launches.
- For instance, in 2020, i-SENS, Inc. launched the ACR Cartridge for monitoring kidney functioning by doing quantitative albumin/creatinin ratio testing.
Developmental stages of advanced hematology diagnostics require huge expenditure. With rise in the number of new entrants, overall research and development expenses are projected to rise exponentially, along with collaborations and licensing agreements with several research institutes.
With constantly rising healthcare spending in developed countries, demand for hematology diagnostics is also expected to rise.
Fact MR expects the Americas market for hematology diagnostics to rise at 5% CAGR from 2021 to 2031.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is High Prevalence of Anemia Affecting Demand for Hematology Diagnostics across the Americas?
Anemia is a diseased condition in which human blood lacks healthy red blood cells. This leads to reduced oxygen level and transport to the organs. It results in various other problems such as fatigue, shortness of breath, light-headedness, and fast heartbeat.
In this, diagnosis plays a vital role because the treatment required for anemia is directly depending on the result of the blood test. For instance, in case of iron deficiency, iron supplements can be used. Similarly, in case of low vitamin levels, vitamin B supplements can be used to treat the condition.
Anemia is more common in women. According to World Bank data, approximately 30% women of reproductive age suffered from anemia in 2018 across the world. This can be controlled by developing innovative diagnostic kits and advanced treatment methods.
Thus, growing number of anemia cases across the world will create the need for better diagnostics and treatment options, thus driving demand for hematology tests for anemia.
What are the Key Opportunities for Providers of Hematology Diagnostics in the Americas?
Advancements in technology have led to market expansion. Point of care diagnosis methods are gaining popularity. During this COVID-19 pandemic, people changed their priorities. Instead of lab-based systems they wanted to use self-diagnosis kits in order to follow COVID-19 guidelines and stay at home to avoid visits to diagnostic centers and hospitals.
Thus, various emerging market players are mainly engrossed in developing advanced kits for hematology diagnosis, such as point of care hematology testing.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Restraining Demand for Hematology Diagnostics across the Americas?
Large number of manufacturers creates competition that has resulted in putting pressure on the cost of products provided by them.
In order to compete with other manufacturers, they have to offer good amount of discounts on their products, which is adding to the already existing pressure on the prices of test kits.
Thus, pricing of products is going to restrain market growth for hematology diagnostics over the coming years.
Country-wise Insights
How Lucrative is the Opportunity in the U.S. for Hematology Diagnostic Equipment Manufacturers?
The U.S. held nearly 80% share of the market in North America in 2020. In the U.S., the dominant stance is due to research collaborations and license agreements for healthcare products. Rising technological advancements gives an opportunity to hematology test kit companies in the U.S. to innovative products for the diagnosis of blood-related diseases such as blood cancer and anemia.
Moreover, key players focus on strategies such as new product launches for hematology diagnosis.
- For instance, BioMedomics Inc. made Ade Adebisi, professional rugby player, the sickle cell disease advocate brand ambassador for its product Sickle SCAN in August 2019.
What is Driving Revenue Generation from Hematology Diagnostics in Canada?
Canada accounted for nearly 20% of the North American market share in 2020. Key factor for speeding growth in Canada is the presence of leading players.
- For instance, BTNX Inc., with its headquarters in Ontario, Canada, is a biotechnology company and a leading manufacturer of rapid diagnostic products that develops information technology systems to run rapid diagnostic test outputs.
How is the Brazil Market for Hematology Diagnostics Faring?
Brazil accounted for over 42% market share of Latin America in 2020. Gradual improvement in healthcare in the country over the past decade has contributed to the growth of the market. Additionally, rise in patient pool in the country is another significant contributing factor for market growth.
What is Scope of Growth for Hematology Diagnostics in Mexico?
The market for hematology diagnostic instruments in Mexico is set to exhibit 8.3% CAGR, and is expected to account for nearly 30% of the Latin American market share. Emerging markets have a great opportunity for expansion in hematology diagnostics. This is due to continuous improvements towards the concept of diagnosis and treatments.
Category-wise Insights
What are Blood Typing Kits Highly Demand across the Americas?
Blood typing kits is the most lucrative segment in the market and is expected to expand at a CAGR of 4% during the forecast period. Blood typing kits are widely used in the healthcare sector to determine exact blood profiles.
What is the Market Share of Lab-based testing in Hematology Diagnostics?
Lab-based testing will continue to dominate the market and is expected to hold around 80% of market share through the end of 2031. This is due to rising blood disorders and the level of accuracy attained in lab-based tests that have made them widely accepted.
What is the Impact of COVID-19 on the Hematology Testing Market in the Americas?
The COVID-19 pandemic is expected to moderately impact the growth of the hematology tests market in the Americas. This is mainly due to rising demand of point of care testing.
Also, on the other hand, the pandemic has enhanced online sales, and many users prefer getting home delivery of and testing kits to avoid exposure to the virus and follow social distancing guidelines.
Competitive Landscape
Manufacturers of hematology diagnostic kits in the Americas are primarily aiming to carry out strategic acquisitions and launch innovative products in the market.
- For instance, Biomerieux acquired Invisible Sentinel, a company that manufactured rapid and accurate molecular diagnostic products, in 2019.
- Similarly, in 2018, Danaher acquired Integrated DNA Technologies, a nucleic acid manufacturing company, which strengthen the life science department of Danaher.
Americas Hematology Diagnostics Market Report Scope
|
Report Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value/ Units in Million for Volume |
|
Key Regions Covered |
North America and Latin America |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
| Report Coverage |
|
| Customization & Pricing |
Available upon Request |
Categorization by Americas Hematology Diagnostics Industry Research
-
By Kit
- Hematology Anemia and Iron Test Kits
- Hematology Folic Acid Testing Kits
- Hematology Sickle Cell Screening Kits
- Hematology PT/INR Testing Kits
- Hematology D-dimer Testing Kits
- Hematology Blood Typing Kits
- Hematology Leukemia Testing Kits
- Hematology Sepsis Testing Kits
- Hematology Antibiotic Resistance Panels
- Hematology Bacterial & Fungal Panels
-
By Modality
- Point of Care
- Lab-based testing
-
Distribution Channel
- Hematology Diagnostics at Hospitals
- Hematology Diagnostics at Diagnostic Laboratories
- Hematology Diagnostics at Cancer Research Institutes
- Hematology Diagnostics through Retail Pharmacies
- Hematology Diagnostics through Drug Stores
Table of Content
1. Executive Summary 1.1. Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusion & Exclusion 3. Key Market Trends 3.1. Key Trends Impacting the Hematology Diagnostics Market 3.2. Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. GDP Growth Outlook 4.1.2. Healthcare Industry Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Increasing Prevalence of Chronic Diseases 4.2.2. Diagnostic Rate (%) 4.2.3. Increasing Self-Testing among Geriatric Population 4.2.4. Cost Per Test 4.2.5. Brand Promotional Activities 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 5. Market Context 5.1. Recent developments in Product Launches and approvals 5.2. Technology Assessment 5.3. Key Marketing Strategies, by Manufacturers 5.4. Regulatory Scenario 6. COVID19 Crisis Analysis 6.1. Current COVID19 and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 financial analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue by Test 6.4.2. Revenue by Country 6.5. 2020 Market Scenario 6.6. Recovery Scenario – Short term, Midterm and Long Term Impact 7. Americas Hematology Diagnostics Market Value Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Kit Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis by Kit Type, 2016-2020 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Kit Type, 2021-2031 8.3.1. Anaemia and Iron Test kits 8.3.2. Folic Acid Testing Kits 8.3.3. Sickle Cell Screening Kits 8.3.4. PT/INR Testing Kits 8.3.5. D-dimer Testing kits 8.3.6. Blood Typing Kits 8.3.7. Leukaemia Testing Kits 8.3.8. Sepsis Testing Kits 8.3.9. Antibiotic Resistance Panels 8.3.10. Bacterial & Fungal Panels 8.4. Market Attractiveness Analysis by Kit Type 9. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Modality 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis by Modality, 2016-2020 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Modality, 2021-2031 9.3.1. Point of Care 9.3.2. Lab based testing 9.4. Market Attractiveness Analysis by Modality 10. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031 10.3.1. Hospitals 10.3.2. Diagnostic Laboratories 10.3.3. Cancer Research Institutes 10.3.4. Retail Pharmacies 10.3.5. Drug Store 10.3.6. Online Sales Channels 10.4. Market Attractiveness Analysis by Distribution Channel 11. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 11.3.1. North America 11.3.2. Latin America 11.4. Market Attractiveness Analysis By Region 12. North America Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Kit Type 12.3.3. By Modality 12.3.4. By Distribution Channel 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Latin America Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Kit Type 13.3.3. By Modality 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. U.S. Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 14.3.1. By Kit Type 14.3.2. By Modality 14.3.3. By Distribution Channel 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Canada Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 15.3.1. By Kit Type 15.3.2. By Modality 15.3.3. By Distribution Channel 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Deep Dive 17.2.1. BioMedomics, Inc. 17.2.1.1. Overview 17.2.1.2. Product Portfolio 17.2.1.3. Analyst Commentary 17.2.1.4. Key Financials 17.2.1.5. Recent Developments 17.2.1.6. Sales Footprint 17.2.1.7. Strategy Overview 17.2.1.7.1. Marketing Strategy 17.2.1.7.2. Product Strategy 17.2.1.7.3. Channel Strategy 17.2.2. Biomerieux SA 17.2.2.1. Overview 17.2.2.2. Product Portfolio 17.2.2.3. Analyst Commentary 17.2.2.4. Key Financials 17.2.2.5. Recent Developments 17.2.2.6. Sales Footprint 17.2.2.7. Strategy Overview 17.2.2.7.1. Marketing Strategy 17.2.2.7.2. Product Strategy 17.2.2.7.3. Channel Strategy 17.2.3. Abbott Laboratories 17.2.3.1. Overview 17.2.3.2. Product Portfolio 17.2.3.3. Analyst Commentary 17.2.3.4. Key Financials 17.2.3.5. Recent Developments 17.2.3.6. Sales Footprint 17.2.3.7. Strategy Overview 17.2.3.7.1. Marketing Strategy 17.2.3.7.2. Product Strategy 17.2.3.7.3. Channel Strategy 17.2.4. BTNX Inc. 17.2.4.1. Overview 17.2.4.2. Product Portfolio 17.2.4.3. Analyst Commentary 17.2.4.4. Key Financials 17.2.4.5. Recent Developments 17.2.4.6. Sales Footprint 17.2.4.7. Strategy Overview 17.2.4.7.1. Marketing Strategy 17.2.4.7.2. Product Strategy 17.2.4.7.3. Channel Strategy 17.2.5. i-SENS, Inc. (Coagusense Inc.) 17.2.5.1. Overview 17.2.5.2. Product Portfolio 17.2.5.3. Analyst Commentary 17.2.5.4. Key Financials 17.2.5.5. Recent Developments 17.2.5.6. Sales Footprint 17.2.5.7. Strategy Overview 17.2.5.7.1. Marketing Strategy 17.2.5.7.2. Product Strategy 17.2.5.7.3. Channel Strategy 17.2.6. Danaher (Beckman coulter) 17.2.6.1. Overview 17.2.6.2. Product Portfolio 17.2.6.3. Analyst Commentary 17.2.6.4. Key Financials 17.2.6.5. Recent Developments 17.2.6.6. Sales Footprint 17.2.6.7. Strategy Overview 17.2.6.7.1. Marketing Strategy 17.2.6.7.2. Product Strategy 17.2.6.7.3. Channel Strategy 17.2.7. Danaher (Cepheid) 17.2.7.1. Overview 17.2.7.2. Product Portfolio 17.2.7.3. Analyst Commentary 17.2.7.4. Key Financials 17.2.7.5. Recent Developments 17.2.7.6. Sales Footprint 17.2.7.7. Strategy Overview 17.2.7.7.1. Marketing Strategy 17.2.7.7.2. Product Strategy 17.2.7.7.3. Channel Strategy 17.2.8. ELDON BIOLOGICALS A/S 17.2.8.1. Overview 17.2.8.2. Product Portfolio 17.2.8.3. Analyst Commentary 17.2.8.4. Key Financials 17.2.8.5. Recent Developments 17.2.8.6. Sales Footprint 17.2.8.7. Strategy Overview 17.2.8.7.1. Marketing Strategy 17.2.8.7.2. Product Strategy 17.2.8.7.3. Channel Strategy 17.2.9. F. Hoffmann-La Roche Ltd 17.2.9.1. Overview 17.2.9.2. Product Portfolio 17.2.9.3. Analyst Commentary 17.2.9.4. Key Financials 17.2.9.5. Recent Developments 17.2.9.6. Sales Footprint 17.2.9.7. Strategy Overview 17.2.9.7.1. Marketing Strategy 17.2.9.7.2. Product Strategy 17.2.9.7.3. Channel Strategy 17.2.10. Grifols, S.A 17.2.10.1. Overview 17.2.10.2. Product Portfolio 17.2.10.3. Analyst Commentary 17.2.10.4. Key Financials 17.2.10.5. Recent Developments 17.2.10.6. Sales Footprint 17.2.10.7. Strategy Overview 17.2.10.7.1. Marketing Strategy 17.2.10.7.2. Product Strategy 17.2.10.7.3. Channel Strategy 17.2.11. Pro Lab Diagnostics Inc. 17.2.11.1. Overview 17.2.11.2. Product Portfolio 17.2.11.3. Analyst Commentary 17.2.11.4. Key Financials 17.2.11.5. Recent Developments 17.2.11.6. Sales Footprint 17.2.11.7. Strategy Overview 17.2.11.7.1. Marketing Strategy 17.2.11.7.2. Product Strategy 17.2.11.7.3. Channel Strategy 17.2.12. Novacyt Group 17.2.12.1. Overview 17.2.12.2. Product Portfolio 17.2.12.3. Analyst Commentary 17.2.12.4. Key Financials 17.2.12.5. Recent Developments 17.2.12.6. Sales Footprint 17.2.12.7. Strategy Overview 17.2.12.7.1. Marketing Strategy 17.2.12.7.2. Product Strategy 17.2.12.7.3. Channel Strategy 17.2.13. Bio-rad Laboratories 17.2.13.1. Overview 17.2.13.2. Product Portfolio 17.2.13.3. Analyst Commentary 17.2.13.4. Key Financials 17.2.13.5. Recent Developments 17.2.13.6. Sales Footprint 17.2.13.7. Strategy Overview 17.2.13.7.1. Marketing Strategy 17.2.13.7.2. Product Strategy 17.2.13.7.3. Channel Strategy 17.2.14. ASURAGEN, INC. 17.2.14.1. Overview 17.2.14.2. Product Portfolio 17.2.14.3. Analyst Commentary 17.2.14.4. Key Financials 17.2.14.5. Recent Developments 17.2.14.6. Sales Footprint 17.2.14.7. Strategy Overview 17.2.14.7.1. Marketing Strategy 17.2.14.7.2. Product Strategy 17.2.14.7.3. Channel Strategy 17.2.15. CTK Biotech, Inc. 17.2.15.1. Overview 17.2.15.2. Product Portfolio 17.2.15.3. Analyst Commentary 17.2.15.4. Key Financials 17.2.15.5. Recent Developments 17.2.15.6. Sales Footprint 17.2.15.7. Strategy Overview 17.2.15.7.1. Marketing Strategy 17.2.15.7.2. Product Strategy 17.2.15.7.3. Channel Strategy 18. Assumptions and Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 02: Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 03: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality
Table 04: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 05: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 06: U.S Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 07: U.S Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 08: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality
Table 09: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 10: Canada Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 11: Canada Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 12: Canada Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality
Table 13: Canada Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 14: Latin America Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 15: Latin America Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Table 16: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality
Table 17: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Table 18: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Hematology Diagnostics Market Volume (Units) Analysis, 2016-2020
Figure 02: Hematology Diagnostics Market Volume (Units) & Y-o-Y Growth (%), 2021–2031
Figure 03: and Regional Average Pricing Analysis Benchmark - USD (per kit) By Kit Type (2020)
Figure 04: Hematology Diagnostics Market Value (US$ Mn) Analysis, 2016-2020
Figure 05: Hematology Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021–2031
Figure 06: Hematology Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 07: Hematology Diagnostics Market Analysis by Kit Type –2021 & 2031
Figure 08: Hematology Diagnostics Market Y-o-Y Growth Projections by Kit Type, 2021 – 2031
Figure 09: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Figure 10: Hematology Diagnostics Market Analysis by Modality –2021 & 2031
Figure 11: Hematology Diagnostics Market Y-o-Y Growth Projections by Modality, 2021 – 2031
Figure 12: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality
Figure 13: Hematology Diagnostics Market Analysis by Distribution Channel –2021 & 2031
Figure 14: Hematology Diagnostics Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031
Figure 15: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
Figure 16: Hematology Diagnostics Market Analysis by Region –2021 & 2031
Figure 17: Hematology Diagnostics Market Y-o-Y Growth Projections by Region, 2021 – 2031
Figure 18: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Figure 19: Hematology Diagnostics Market Split By Product Type (2021E)
Figure 20: Hematology Diagnostics Market Split By Modality (2021E)
Figure 21: Hematology Diagnostics Market Split By Distribution Channel (2021E)
Figure 22: U.S Hematology Diagnostics Market Value (US$ Mn), Historical, 2016-2020
Figure 23: U.S Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031
Figure 24: U.S Hematology Diagnostics Market Attractiveness Analysis by Modality, 2021-2031
Figure 25: U.S Hematology Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 26: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type
Figure 27: Hematology Diagnostics Market Split By Product Type (2021E)
Figure 28: Hematology Diagnostics Market Split By Modality (2021E)
Figure 29: Hematology Diagnostics Market Split By Distribution Channel (2021E)
Figure 30: Canada Hematology Diagnostics Market Value (US$ Mn), Historical, 2016-2020
Figure 31: Canada Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031
Figure 32: Canada Hematology Diagnostics Market Attractiveness Analysis 2021-2031, by Modality,
Figure 33: Canada Hematology Diagnostics Market Attractiveness Analysis, 2021-2031 by Distribution Channel
Figure 34: Canada Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Kit Type
Figure 35: Latin America Hematology Diagnostics Market Split By Product Type (2021E)
Figure 36: Latin America Hematology Diagnostics Market Split By Modality (2021E)
Figure 37: Latin America Hematology Diagnostics Market Split By Distribution Channel (2021E)
Figure 38: Latin America Hematology Diagnostics Market Value (US$ Mn), Historical, Forecast 2016-2020
Figure 39: Latin America Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031
Figure 40: Latin America Hematology Diagnostics Market Attractiveness Analysis by Modality, 2021-2031
Figure 41: Latin America Hematology Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 42: Latin America Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Kit Type
Figure 43: Latin America Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the Americas hematology diagnostics market currently worth?
The Americas hematology diagnostics market is estimated to be valued at US$ 276.5 Mn in 2021.
What is the demand outlook for hematology diagnostic kits in the Americas?
The market is expected to reach a value of US$ 451 Mn by the end of 2031, with sales revenue expected to register a CAGR of 5% over the period.
What are the key trends shaping the market for hematology diagnostics?
The market is benefitted from collaborative efforts and initiatives to launch cost-effective hematology test kits.
Which are the top 3 countries driving demand for hematology tests in the Americas?
The U.S., Canada, and Brazil are expected to drive most demand for hematology diagnostics kits over the coming years.
What is the North America market outlook for hematology diagnostics?
North America is the dominant market for hematology diagnostic services and products in the Americas, and is expected to account for 2/3 market share in 2031.
At what percentage is the market for hematology diagnostics going to register growth in Latin America?
Demand of hematology diagnostics is anticipated to register a growth rate of 6.4% in the Latin American region.
Which countries account for major share of hematology diagnostics in the Americas?
The U.S. and Canada are dominating the hematology diagnostics space in terms of services.
Who are the key providers of hematology diagnostic kits and services in the Americas?
BioMedomics, Inc., Biomerieux SA, Abbott Laboratories, BTNX Inc., i-SENS, Inc. (Coagusense Inc.), Danaher, ELDON BIOLOGICALS A/S, F. Hoffmann-La Roche Ltd, Grifols, S.A, Pro Lab Diagnostics Inc., Novacyt Group, Bio-rad Laboratories, ASURAGEN, INC., and
What are the key market statistics for Brazil and Mexico in hematology diagnostics?
Demand for hematology diagnostics in Brazil and Mexico is expected to witness growth of 5% and 8.3%, respectively, through 2031.
Americas Hematology Diagnostics Market